By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



1234 Central Avenue

Yonkers  New York  10704  U.S.A.
Phone: 914-779-9300 Fax:



Company News
CureMark Completes Enrollment For Its Phase III Clinical Trial For Children With Autism - The Blüm Study 9/25/2017 8:10:46 AM
CureMark Release: Blüm Study - A Phase 3 Clinical Trial For Children With Autism 9/22/2016 8:58:55 AM
CureMark CEO Dr. Joan Fallon To Be Featured Speaker At Two Scientific Conferences 10/20/2015 11:18:33 AM
Jzaneen Lalani Joins CureMark As Chief Operating Officer 10/14/2015 10:14:54 AM
CureMark CEO Joan Fallon To Present Power Talk At Athena Center For Leadership Studies September 29 9/23/2015 10:39:55 AM
CureMark Secures $20 Million In Equity Financing 7/13/2015 7:23:10 AM
CureMark, Launches New Phase III Trial In Expanded Population Of Children With Autism 5/11/2015 7:25:17 AM
CureMark CEO Delivers Keynote Speech At Epigenetics Conference 12/17/2014 10:14:48 AM
CureMark CEO Receives 2014 Gold Maverick Of The Year Recognition At The Stevie Awards For Women In Business 11/18/2014 2:57:00 PM
CureMark Named To The Red Herring Top 100 5/21/2014 10:21:12 AM